Play Video

An innovative biotech startup

About Cebiotex

Cebiotex is an innovative biotechnology startup, spin-off of the Polytechnic University of Catalonia (Universitat Politècnica de Catalunya – UPC) and the Sant Joan de Déu Barcelona Children’s Hospital (HSJD) We investigate and develop biomedical solutions with the objective of addressing unmet medical needs in both paediatric and adult oncology.

Our story

The Cebiotex project started when 6-year-old Sara passed away after 4 years fighting child cancer. This experience motivated the founder Joan Bertran to investigate and develop new biomaterials that could bring medical solutions to paediatric and adult oncology, expanding to the health sector.

After three years of combined scientific work, Cebiotex was constituted in 2012 as a result of the interaction between researchers from the UPC and the HSJD. Our spin-off started its activity after closing the first funding round in 2015.

Our mission

Our current mission is o provide solutions to patients with cancer, both paediatric and adult. Our future perspective is to also provide solutions to patients who suffer from infections or who need advanced therapies for marrow and cartilage regeneration, marrow injuries, etc.

Our first drug, CEB-01, meets an oncological and surgical need that has not yet been met by helping surgeons in their surgical oncology interventions.

Our objective is for CEB-01 to become part of the Standard of Care in surgical oncology.

“Cancer preoccupies us, and child cancer occupies us.”

Our work

At Cebiotex we have created a new medical product through our proprietary technology in nanofiber engineering, alongside the medical and scientific teams of the Sant Joan de Déu Barcelona Children’s Hospital (HSJD) and the Polytechnic University of Catalonia (UPC).

We are working on the development of the drug CEB-01 with the objective of meeting unmet medical needs in oncology, and ensure surgeons and patients that the surgical site is free from cancerous cells.

Our story

The Cebiotex project started when 6-year-old Sara passed away after 4 years fighting child cancer. This experience motivated the founder Joan Bertran to investigate and develop new biomaterials that could bring medical solutions to paediatric and adult oncology, expanding to the health sector.

After three years of combined scientific work, Cebiotex was constituted in 2012 as a result of the interaction between researchers from the UPC and the HSJD. Our spin-off started its activity after closing the first funding round in 2015.

Our mission

Our current mission is o provide solutions to patients with cancer, both paediatric and adult. Our future perspective is to also provide solutions to patients who suffer from infections or who need advanced therapies for marrow and cartilage regeneration, marrow injuries, etc.

Our first drug, CEB-01, meets an oncological and surgical need that has not yet been met by helping surgeons in their surgical oncology interventions.

Our objective is for CEB-01 to become part of the Standard of Care in surgical oncology.

Committed expert professionals

Team

Cebiotex is an innovative biotechnology startup, spin-off of the Polytechnic University of Catalonia (Universitat Politècnica de Catalunya – UPC) and the Sant Joan de Déu Barcelona Children’s Hospital (HSJD) We investigate and develop biomedical solutions with the objective of addressing unmet medical needs in both paediatric and adult oncology.

Joan Bertran

Joan Bertran

MBA, FOUNDER AND CHIEF EXECUTIVE OFFICER

Imma Barber

MBA, CHIEF BUSINESS OFFICER

Luc Marti

PHD, MBM, CHIEF OPERATIONS OFFICER

Lucas Krauel

MD, PHD, FOUNDER AND CHIEF SURGICAL OFFICER

Jose Antonio Tornero

PHD, FOUNDER AND CHIEF TECHNOLOGY OFFICER

Administration Committee

Joan Bertran, MBA, President and Advisor
Javier Merino, MBA, Secretary
Jose Antonio Tornero, PhD, Advisor
Lucas Krauel, MD, PhD, Advisor
Xavier Luria, MD, Independent Advisor
Antonio Villaró, MBA, Independent Advisor
Carolina La Valle, MBA, Independent Advisor
Marc Ramis, PhD, MBA, Independent Advisor
Emili Bargalló, MBA, Observer
Universitat Politècnica de Catalunya, UPC, Observer

Advisors

Xavier Luria, MD, Regulatory Affairs
Jordi Petit, MBA, Financial Advisor
Antonio Pérez, MD, PhD, Clinical Development Expert

Clinical Advisors

Jaume Mora, Founder and Peadiatric Chairman SAB
Antonio López Pousa, MD, PhD, Clinical Trial Coordinating Researcher
Ana Sebio, MD, PhD, Clinical Trial Researcher
J. A. González, MD, PhD, Clinical Trial Researcher
Robert Maki, MD, PhD, FACP, Sarcoma KOL, USA
Alessandro Gronchi, MD, PhD, Sarcoma KOL, Italia
Silvia Stacchiotti Gronchi, MD, PhD, Sarcoma KOL, Italia

Cebiotex Biomedical Nanofibers S.L.

Contact us

Pier01, Barcelona Tech City

Subscribe to our Newsletter

Join our mailing list to receive the latest news and updates from Cebiotex.